Tecan and Promega offer variable volume DNA isolation

  • Email
  • Print

Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples. Designed to meet the needs of biobanks and high throughput genomic laboratories, the Freedom EVO® ­ HSM workstation provides reliable walkaway extraction of gDNA from large volume blood samples using Promega’s proven ReliaPrep™ Large Volume HT gDNA Isolation System.

The Freedom EVO - HSM workstation is designed to streamline biobanking workflows, offering intelligent one-tube gDNA extraction from up to 32 samples in less than four hours. The compact system is controlled by Tecan’s intuitive TouchTools™ touchscreen interface, and features pre-installed protocols that have been rigorously tested and verified by Promega. Using the platform’s liquid level detection function, the system is able to automatically calculate the reagent volumes for each sample, ensuring efficient walkaway extraction of high quality DNA from 1-10 ml of blood and meeting the specific requirements of next generation sequencing methods.

Caroline Huber, Senior Market Manager at Tecan, commented: “We are very pleased to be working in close collaboration with Promega. Tecan’s expertise in laboratory automation is a great fit with Promega’s genomics tools and reagents, creating a truly unique solution for biobanking applications, backed by the technical support and experience of both companies.”

“This really is an ideal set up for laboratories,” added Promega’s Genomics Marketing Director Tim Sheehy. “As a reagent solutions provider, we know that sample requirements can change from one project to another. The efficiency and reliability of Tecan’s Freedom EVO system make it the ideal platform for integrating the ReliaPrep Large Volume HT gDNA Isolation System, offering customers the flexibility to handle a wide range of sample types and volumes.”

To find out more about Tecan’s Freedom EVO - HSM workstation, visit www.tecan.com/reliaprep

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).

About Promega

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

contact
Tecan Trading AG
Cornelia Kegele / Antonietta Allocca
Seestrasse 103, CH-8708 Männedorf
Tel  +41 (0)44 922 81 11, Fax +41 (0)44 922 81 12
info@tecan.com  www.tecan.com